Table 2.
Details for the identified microRNA biomarkers
| microRNA ID | Adj.p value (PPCa vs MPCa) | log2 (FC) | Target number | NSR | TFP | UTP |
|---|---|---|---|---|---|---|
| miR-204-5p | 3.43E−08 | − 2.0896 | 21 | 13 | 0.2857 | 0.3846 |
| miR-101-3p | 1.26E−08 | − 1.0684 | 24 | 3 | 0.2917 | 0.3333 |
| miR-145-5p | 8.00E−25 | − 3.2157 | 12 | 3 | 0.2500 | 0.3333 |
| miR-198 | 7.67E−05 | 1.2564 | 12 | 5 | 0.3333 | 0.2000 |
| miR-152 | 3.67E−08 | − 1.0146 | 17 | 6 | 0.2941 | 0.1667 |
PPCa primary prostate cancer; MPCa metastatic prostate cancer; adj. p value adjusted p value; FC fold change; NSR number of single-line regulation; TFP transcription factor gene percentage; UTP percentage of transcription factor genes in microRNA unique targets